Abstract: A 9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione compound, its synthesis, and its use as an antimicrobial agent.
Type:
Grant
Filed:
January 16, 2024
Date of Patent:
May 7, 2024
Assignee:
KING FAISAL UNIVERSITY
Inventors:
Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed
Abstract: The present invention relates to a modified-release composition comprising orlistat and acarbose, comprising individually distinct parts with different release patterns: a) a first part, G1, comprising from about 5 to about 70% w/w of the total dose of acarbose, b) a second part, G2A, comprising from about 30 to about 95% w/w of the total dose of acarbose, c) a third part, G2B, comprising from about 10 to about 90% w/w of the total dose of orlistat, and d) a fourth part, G3, comprising from about 10 to about 80% w/w of the total dose of orlistat, and the total concentration of acarbose and orlistat, respectively, in the composition is 100% w/w.
Type:
Grant
Filed:
January 24, 2020
Date of Patent:
May 7, 2024
Assignee:
EMPROS PHARMA AB
Inventors:
Göran Alderborn, Anders Forslund, Ulf Holmbäck, Hans Lennernäs, Jan Stefan Persson Grudén
Abstract: A 9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione compound, its synthesis, and its use as an antimicrobial agent.
Type:
Grant
Filed:
October 23, 2023
Date of Patent:
May 7, 2024
Assignee:
KING FAISAL UNIVERSITY
Inventors:
Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed
Abstract: The non-therapeutic, cosmetic, oral use of a composition as an active ingredient for whitening and/or lightening the skin and/or depigmenting the skin, in particular for reducing the size of brown spots, including at least cystine and glutathione in a cystine/glutathione ratio ranging from 1.5 to 4, the composition advantageously further comprising glycine and/or glutamine Preferably, the composition also includes at least one component selected from the group formed by zinc or one of its salts, copper or one of its salts, selenium or one of its salts, vitamins B, in particular B3, B5, B6 and/or B8, vitamin E, melon juice extracts, horsetail extracts and mixtures of these components.
Abstract: A pharmaceutical composition is described which includes diclofenac as an active ingredient. The pharmaceutical composition further includes a (meth)acrylic polymer which has a specific solubility and/or a particular functional group in one polymer component.
Type:
Grant
Filed:
April 19, 2013
Date of Patent:
April 16, 2024
Assignee:
Glatt AG
Inventors:
Frédéric Gerber, Marie Guhmann, Norbert Pöllinger
Abstract: A process is described for the preparation of a hair treatment composition, which comprises the following process steps: a) Providing a water phase (Ia) comprising water and optionally other components and heating the water phase to a temperature of from about 70 to about 95° C., b) Providing an oil phase (Ib) comprising at least one oil and at least one emulsifier, and adding the oil phase to the heated water phase from step a), c) Homogenize the mixture from step b), d) Cooling the emulsion resulting from step c) to a temperature of from about 35 to about 45° C. and optionally adding further active ingredients, e) Filling of the emulsion resulting from step d) into preferably transparent containers, whereby in the resting state after from about 10 to about 90 minutes a separation into a water phase (II) and an emulsion phase (IIb) occurs.
Abstract: The present invention relates to topical compositions comprising at least one polar oil and a micronized 1,4-di(benzoxazol-2?-yl)benzene having a mean particle size of at most 300 nm as well as to the use of such a micronized 1,4-di(benzoxazol-2?-yl)benzene to reduce the transfer of such oils to surfaces.
Type:
Grant
Filed:
March 19, 2019
Date of Patent:
March 19, 2024
Assignee:
DSM IP ASSETS B.V.
Inventors:
Christine Mendrok-Edinger, Alexander Schlifke-Poschalko
Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
Type:
Grant
Filed:
October 6, 2021
Date of Patent:
February 27, 2024
Assignee:
CEVA SANTE ANIMALE
Inventors:
Anne-Claire Le Meur, Florence Guimberteau
Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
Type:
Grant
Filed:
October 6, 2021
Date of Patent:
February 20, 2024
Assignee:
CEVA SANTE ANIMALE
Inventors:
Anne-Claire Le Meur, Florence Guimberteau
Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
Type:
Grant
Filed:
May 13, 2022
Date of Patent:
February 20, 2024
Assignee:
CEVA SANTE ANIMALE
Inventors:
Anne-Claire Le Meur, Florence Guimberteau
Abstract: Long-lasting fragrance compositions are provided for. The fragrance compositions can include at least one fragrance compound and a glycoside. The glycoside can be selected from a Steviol glycoside, a glucosylated Steviol glycoside, a derivative of a Steviol glycoside, a derivative of a glucosylated Steviol glycoside, or combinations thereof. Also provided for are products including a long-lasting fragrance composition as above. The products can include perfumes, body care products, cosmetics, cleaning and laundry products, and the like.
Abstract: Disclosed are a cosmetic composition having increased skin contact and makeup persistence and a method of manufacturing the same. The method includes: forming a powder continuous phase by rapidly mixing a powder and a film-forming agent; and obtaining a cosmetic composition in which a surface of the powder is compounded with the film-forming agent by heating the powder continuous phase for a predetermined time. In an embodiment, the cosmetic composition is manufactured by the method. In an embodiment, the cosmetic composition includes 5 wt % to 30 wt % of a powder, 0.1 wt % to 10 wt % of a film-forming agent, 10 wt % to 30 wt % of a silicone oil, and 0.1 wt % to 10 wt % of a spherical powder.
Type:
Grant
Filed:
June 17, 2022
Date of Patent:
February 13, 2024
Assignee:
COSMECCA KOREA CO., LTD.
Inventors:
Hyun Dae Cho, Byoung Moon Kim, Yeen Ji Kim, Goo Ho Kwon, Jin Young Kim
Abstract: The present invention relates to a modified release pharmaceutical formulation comprising one or more sustained release granules that may be prepared by over-mixing and hot melt granulation. The invention also relates to disintegrating monolithic modified release tablets comprising the sustained release granules as an internal phase and an immediate release formulation of a drug or drugs as an external phase. The drug release profile from either these granules or these tables may be adjusted by adjusting the percentages of the formulation's components. In one application, the disintegrating monolithic modified release tablets comprise amoxicillin and clavulanate and have a dissolution profile similar to brand and generic “Augmentin XR® Bilayered Extended Release Tablets (1000 mg/62.5 mg)”. The invention also relates to a method of preparing the foregoing sustained release granules.
Abstract: The invention relates to a cosmetic composition, in particular in the form of a liquid cosmetic composition, comprising in a physiological medium (i) at least a plate type filler with refractive index>1.6 and having a particle size between 1 ?m and 20 ?m, preferably between 1 ?m and 15 ?m, (ii) at least a silicon elastomer, preferably a non-emulsifying silicon elastomer, and (iii) at least a filler having an oil absorption capacity greater than or equal to 1 ml/g. The composition is preferably used as a skin care or make-up base or primer intended to decrease the visibility of skin imperfections, in particular the pores and make the pore hiding effect long lasting.
Abstract: Described herein is a hair conditioner composition and methods of using the same, the hair conditioner composition including an effective chelant. The hair conditioner composition further includes one or more high melting point fatty compounds and a cationic surfactant.
Type:
Grant
Filed:
June 22, 2017
Date of Patent:
October 17, 2023
Assignee:
The Procter & Gamble Company
Inventors:
Jennifer Mary Marsh, Casey Patrick Kelly, Mark Robert Sivik
Abstract: The present invention relates to a permanent shaping composition for the permanent deformation of hair comprising, in a cosmetically acceptable carrier, at least one reducing agent comprising a mercapto functional group, at least one alkalizing agent, and a malodor suppressant system comprising at least a first malodor suppressant, herein the first malodor suppressant has a molecular weight of from 100 to 400 g/mol, and wherein the malodor suppressant system has a distribution coefficient log P (octanol/water) of 2 or more.
Type:
Grant
Filed:
September 14, 2017
Date of Patent:
October 10, 2023
Assignee:
WELLA OPERATIONS US, LLC
Inventors:
Moussa Barhoum, Manfred Schmitt, Christine Marie Cahen, Graham Neil McKelvey
Abstract: The present invention relates to a process for the elongation and/or densification of fibers, on a keratin material, characterized in that it employs a composition, especially a cosmetic composition, in particular a makeup composition, comprising at least: —one volatile hydrocarbon-based oil, —particles of at least one polymer surface-stabilized with a stabilizer, and —a hydrophobic film-forming polymer, chosen from hydrocarbon-based block copolymers, hydrocarbon-based resins, and mixtures thereof.
Abstract: A cosmetic ink includes a colorant, a higher alcohol having 3 or more carbon atoms, purified water, an acrylic-based resin, and a film-forming agent. The colorant includes a white-based pigment, a yellow-based pigment, a red-based pigment, and a blue-based pigment. In a coating film of the cosmetic ink, a spectral reflectance curve obtained by measuring spectral reflectances in wavelengths of 400 nm to 700 nm has a first inflection point in a wavelength region of 550 nm or more and 610 nm or less, and a second inflection point in a wavelength region of less than 550 nm; a spectral reflectance at the first inflection point is higher than a spectral reflectance at the second inflection point; and spectral reflectances throughout a wavelength region of more than 580 nm are equal to or higher than a spectral reflectance at a wavelength of 580 nm.
Abstract: The present invention teaches a hair straightening system including formulations that will safely and effectively straighten curly hair for at least 2-3 months after a single application, despite frequent washings of the hair. Methods for obtaining said formulations are disclosed. Hair straightening systems including shampoo and one or more conditioners are also provided.